DMK Pharmaceuticals Corporation (DMKPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 23, 2025, 8:00 PM EDT
DMK Pharmaceuticals Market Cap
DMK Pharmaceuticals has a market cap or net worth of $10.00 as of July 25, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
10.00
Enterprise Value
n/a
Revenue
3.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since April 3, 2009, DMK Pharmaceuticals's market cap has decreased from 29.45M to 10.00, a decrease of -100.00%. That is a compound annual growth rate of -59.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 10.00 | - |
| Dec 31, 2024 | 10.00 | -100.00% |
| Dec 29, 2023 | 7.07M | -72.16% |
| Dec 30, 2022 | 25.39M | -71.81% |
| Dec 31, 2021 | 90.08M | 98.26% |
| Dec 31, 2020 | 45.43M | 5.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 820.28M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.35M |
| Glass House Brands | 417.59M |
| CytoDyn | 367.24M |
| Northwest Biotherapeutics | 367.14M |